Platform
Features
1 follower
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Industries
Headquarters
Employees
Links
Aetna Wun Trombley
17 members
7 members
5 members
2 members
Inceptive
5 followers
Vaxcyte
2 followers
Kyverna Therapeutics
Obsidian Therapeutics
Cargo
Chroma Medicine
Slingshot Biosciences
Araceli Biosciences
Generate Biomedicines
3 followers
SolarBioTech
Cellares
Discover companies